Biden Directs HHS, DOJ To Review Marijuana Scheduling

President Joe Biden has directed HHS and the attorney general to review and potentially reconsider marijuana’s current status as a schedule I drug, the White House announced Thursday (Oct. 6) as Biden moved to pardon all prior federal offenses for possession of marijuana. Marijuana is currently considered a schedule I drug under the Controlled Substances Act. Schedule I is reserved for “the most dangerous substances,” and includes heroin and LSD, the White House said Thursday. Not even fentanyl and methamphetamine...
Article Type: 
Tags: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 10/14/2022
FDA Volume: 
Vol. 28, No. 41
Author: 

Industry: Better NIST Cyber Guidance Needed For Small Providers, Telehealth

A key industry cybersecurity group is urging HHS and the National Institute of Standards to emphasize the importance of telehealth providers migrating to more secure platforms, given the eventual end of the COVID-19 public health emergency that has allowed for the use of less-secure platforms not originally built for telehealth. The recommendation is part of a broader letter from the Health Sector Coordinating Council’s Cybersecurity Working Group raising concerns NIST’s guide for protecting health information from cybersecurity threats should offer...
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 
Topics: 

Questions About Race, Ethnicity Should Be Adjusted To Better Understand Health Disparities

States need to collect more nuanced information about patients’ race and ethnicity, including adjusting the way they ask questions to better match how patients identify and increase the likelihood they will respond, analysts said at an Alliance for Health Policy webinar Thursday (Oct. 6). Because there is no federal standard for how racial and ethnic data should be collected, states create their own, which are often inconsistent with each other. Arielle Mir, vice president of health care at Arnold Ventures,...
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 
Topics: 

Patients, Physicians Reluctant To Discuss Social Determinants Of Health

Both patients and providers can be reluctant to discuss social determinants of health factors that are rarely recorded, researchers said at a recent webinar hosted by the Office of the National Coordinator for Health Information Technology, although such data is important for public health responses. Catherine DesRoches, the executive director of Open Notes, an organization that advocates for improving health communication through fully transparent medical records, discussed Open Notes’ findings from a review of available studies on clinicians’ and patients’...
Article Type: 
Site Name: 
InsideHealthPolicy.com
Author: 
Topics: 

Burr Blasts FDA Over Infant Formula Shortage, Threatens To Withold Funds

Senate health committee ranking Republican Richard Burr (NC) on Thursday (Oct. 6) condemned FDA for its recent internal review analyzing the agency’s response to the infant formula shortage, and he threatened to withhold further funding from the agency until it can show more accountability with the funds and authorities it already has. Burr detailed his concerns in a three-page letter sent to FDA Commissioner Robert Califf on Thursday, a little more than two weeks after the agency released a report...
Article Type: 
Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 10/14/2022
FDA Volume: 
Vol. 28, No. 41
Author: 








Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.